By Iain Gilbert
Date: Friday 30 May 2025
(Sharecast News) - Biotechnology firm Aptamer announced on Friday that it has secured a second Optimer discovery and development programme with global consumer goods leader, Unilever.
By Iain Gilbert
Date: Friday 30 May 2025
(Sharecast News) - Contract research organisation Hvivo has received notification that "a significant human challenge trial" contract has been cancelled, alongside a postponement and the cancellation of a smaller study.
By Josh White
Date: Thursday 29 May 2025
(Sharecast News) - Sareum announced the start of a programme of toxicology studies on Thursday, for its lead TYK2/JAK1 inhibitor - SDC-1801 - marking a key step toward phase two clinical development.
Price | 21,228.55 |
Closing Price Change | 545.13 |
% Change | 2.64 % |
30-May-25 Close | 21,228.55 |
You are here: research